14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
PASW vs AIN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
AIN Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 9–1 Matrix Metrics)
AIN Overall Winner
6-Pillar Tally: PASW 1 – 4 AIN (1 Tie)
Matrix Metrics: PASW 1 – 9 AIN
As of Nov 20, 2026, Albany International Corp Class A (AIN) is the stronger overall head-to-head candidate over Ping An Biomedical Co., Ltd. (PASW) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PASW carries a Unified Composite Score of 59.1/100 (HOLD) at $1.13 (N/M Forward P/E, -41.3% operating margin), whereas AIN carries 32.8/100 (SELL) at $62.20 (19.7x Forward P/E, 12.4% operating margin).
Composite vs. Pillar Nuance: While PASW currently prints a higher short-term Unified Composite Score (59.1/100 HOLD vs. AIN 32.8/100 SELL), AIN captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (12.4% vs. -41.3% operating margin) and revenue trajectory (+33.7% vs. -47.4% YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PASW vs AIN. Trailing 12-month operating profitability (PASW -41.3% vs AIN 12.4%) and valuation multiples (PASW N/M vs AIN 19.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Textile Manufacturing value chain with $3.6M market capitalization and -41.3% operating margin.
OpEx & R&D Reinvestment50.6% of Rev ($13M)
90D Engineering Disclosures0 Published
AIN Moat ProfileCyclical / Execution-Driven Positioning
Textile Manufacturing Operator
Competes within the Textile Manufacturing value chain with $1.8B market capitalization and 12.4% operating margin.
OpEx & R&D Reinvestment21.8% of Rev ($286M)
90D Engineering Disclosures0 Published
Investor FAQ PASW vs AIN Key Questions & Quantitative Answers
As of Nov 20, 2026, Albany International Corp Class A (AIN) is the stronger overall head-to-head candidate over Ping An Biomedical Co., Ltd. (PASW) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PASW carries a Unified Composite Score of 59.1/100 (HOLD) at $1.13 (N/M Forward P/E, -41.3% operating margin), whereas AIN carries 32.8/100 (SELL) at $62.20 (19.7x Forward P/E, 12.4% operating margin). Composite vs. Pillar Nuance: While PASW currently prints a higher short-term Unified Composite Score (59.1/100 HOLD vs. AIN 32.8/100 SELL), AIN captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (12.4% vs. -41.3% operating margin) and revenue trajectory (+33.7% vs. -47.4% YoY).
AIN leads the Growth & Scale pillar: PASW posts -47.4% YoY revenue growth and +0.0% YoY earnings growth on $26M TTM revenue (9.3% gross margin, -41.3% operating margin), compared with AIN at +33.7% YoY revenue growth and +98.8% YoY earnings growth on $1.31B TTM revenue (34.2% gross margin, 12.4% operating margin). On trailing 12-month operating scale, PASW generates $26M in USD-normalized revenue versus $1.31B for AIN. In operating R&D and SG&A reinvestment, PASW deploys 50.6% of Rev ($13M) (0 90-day corporate R&D disclosures) versus 21.8% of Rev ($286M) (0 disclosures) for AIN.
AIN screens cheaper on headline valuation multiples. PASW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-41.3% EBITDA margin), whereas AIN trades at 19.7x Forward P/E, 21.4x Trailing P/E, 1.44x PEG, and 1.4x EV/Revenue (18.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PASW (-11.3% ROE) versus AIN (11.6% ROE) capital efficiency.
In options market volatility and institutional positioning, PASW carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-10.07β · 11691% Vol realized risk). By comparison, AIN carries 89.0% implied volatility (30th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.93β · 51% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.